-
1
-
-
0030935510
-
Macrocephaly-cutis marmoratatelangiectaticacongenita: A distinct disorder with developmental delay and connective tissue abnormalities
-
PMID: 9129744
-
Moore CA, Toriello HV, Abuelo DN, Curry CJ, Hall BD, Higgins JV, et al. Macrocephaly-cutis marmoratatelangiectaticacongenita: a distinct disorder with developmental delay and connective tissue abnormalities. Am J Med Genet.1997; 70:67-73. PMID: 9129744
-
(1997)
Am J Med Genet
, vol.70
, pp. 67-73
-
-
Moore, C.A.1
Toriello, H.V.2
Abuelo, D.N.3
Curry, C.J.4
Hall, B.D.5
Higgins, J.V.6
-
2
-
-
84864400015
-
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
-
PMID: 22729224
-
Rivière JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012; 44:934-940. doi: 10.1038/ng.2331 PMID: 22729224
-
(2012)
Nat Genet
, vol.44
, pp. 934-940
-
-
Rivière, J.B.1
Mirzaa, G.M.2
O'Roak, B.J.3
Beddaoui, M.4
Alcantara, D.5
Conway, R.L.6
-
3
-
-
84899650142
-
De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome
-
PMID: 24705253
-
Mirzaa GM, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, Vanstone M, et al. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet. 2014; 46:510-515. doi: 10.1038/ng.2948 PMID: 24705253
-
(2014)
Nat Genet
, vol.46
, pp. 510-515
-
-
Mirzaa, G.M.1
Parry, D.A.2
Fry, A.E.3
Giamanco, K.A.4
Schwartzentruber, J.5
Vanstone, M.6
-
4
-
-
84862129718
-
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome
-
PMID: 22658544
-
Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet. 2012; 90:1108-1115. doi: 10.1016/j.ajhg.2012.05.006 PMID: 22658544
-
(2012)
Am J Hum Genet
, vol.90
, pp. 1108-1115
-
-
Kurek, K.C.1
Luks, V.L.2
Ayturk, U.M.3
Alomari, A.I.4
Fishman, S.J.5
Spencer, S.A.6
-
5
-
-
0032476038
-
Clinical differentiation between Proteus syndrome and hemihyperplasia: Description of a distinct form of hemihyperplasia
-
PMID: 9781913
-
Biesecker LG, Peters KF, Darling TN, Choyke P, Hill S, Schimke N, et al. Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia. Am J Med Genet. 1998; 79:311-318. PMID: 9781913
-
(1998)
Am J Med Genet
, vol.79
, pp. 311-318
-
-
Biesecker, L.G.1
Peters, K.F.2
Darling, T.N.3
Choyke, P.4
Hill, S.5
Schimke, N.6
-
6
-
-
84864409793
-
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
-
PMID: 22729222
-
Lindhurst MJ, Parker VE, Payne F, Sapp JC, Rudge S, Harris J, et al. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet. 2012; 44:928-933. doi: 10.1038/ng.2332 PMID: 22729222
-
(2012)
Nat Genet
, vol.44
, pp. 928-933
-
-
Lindhurst, M.J.1
Parker, V.E.2
Payne, F.3
Sapp, J.C.4
Rudge, S.5
Harris, J.6
-
7
-
-
84921342741
-
PIK3CA-Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation
-
PMID: 25557259
-
Keppler-Noreuil KM, Rios JJ, Parker VER, Semple RK, Lindhurst MJ, Sapp JC, et al. PIK3CA-Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation. Am J Med Genet Part A 2014; 167A:287-295. doi: 10.1002/ajmg.a.36836 PMID: 25557259
-
(2014)
Am J Med Genet Part A
, vol.167 A
, pp. 287-295
-
-
Keppler-Noreuil, K.M.1
Rios, J.J.2
Parker, V.E.R.3
Semple, R.K.4
Lindhurst, M.J.5
Sapp, J.C.6
-
8
-
-
11144358645
-
High frequency of mutations of the PIK3CA gene in human cancers
-
PMID: 15016963
-
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004 304:554. PMID: 15016963
-
(2004)
Science
, vol.304
, pp. 554
-
-
Samuels, Y.1
Wang, Z.2
Bardelli, A.3
Silliman, N.4
Ptak, J.5
Szabo, S.6
-
9
-
-
14144252004
-
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
-
PMID: 15647370
-
Kang S, Bader AG, Vogt PK. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A. 2005; 102:802-807. PMID: 15647370
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 802-807
-
-
Kang, S.1
Bader, A.G.2
Vogt, P.K.3
-
10
-
-
84859088981
-
A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation
-
27 PMID: 22457331
-
Dalle Pezze P, Sonntag AG, Thien A, Prentzell MT, Gödel M, Fischer S, et al. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci Signaling. 2012;27;5(217):ra25. doi: 10.1126/scisignal.2002469 PMID: 22457331
-
(2012)
Sci Signaling
, vol.5
, Issue.217
, pp. ra25
-
-
Dalle Pezze, P.1
Sonntag, A.G.2
Thien, A.3
Prentzell, M.T.4
Gödel, M.5
Fischer, S.6
-
11
-
-
79953216041
-
Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate
-
PMID: 21310961
-
Gan X, Wang J, Su B, Wu D. Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 2011; 286:10998-11002. doi: 10.1074/jbc.M110.195016 PMID: 21310961
-
(2011)
J Biol Chem
, vol.286
, pp. 10998-11002
-
-
Gan, X.1
Wang, J.2
Su, B.3
Wu, D.4
-
12
-
-
84902543512
-
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum
-
Keppler-Noreuil KM, Sapp JC, Lindhurst MJ Parker VE, Blumhorst C, Darling T, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014; 164:1713-1733.
-
(2014)
Am J Med Genet A
, vol.164
, pp. 1713-1733
-
-
Keppler-Noreuil, K.M.1
Sapp, J.C.2
Lindhurst, M.J.3
Parker, V.E.4
Blumhorst, C.5
Darling, T.6
-
13
-
-
84872373752
-
Somatic gain of function in PIK3CA in patients with macrodactily
-
PMID: 23100325
-
Rios JJ, Paria N, Burns DK Israel BA, Cornelia R, Wise CA, et al. Somatic gain of function in PIK3CA in patients with macrodactily. Hum Mol Genet. 2013 22:444-451. doi: 10.1093/hmg/dds440 PMID: 23100325
-
(2013)
Hum Mol Genet
, vol.22
, pp. 444-451
-
-
Rios, J.J.1
Paria, N.2
Burns, D.K.3
Israel, B.A.4
Cornelia, R.5
Wise, C.A.6
-
14
-
-
84928542929
-
AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation
-
Nov 26. [Epub ahead of print]
-
Boscolo E, Coma S, Luks VL Greene AK, Klagsbrun M, Warman ML, et al. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis 2014 Nov 26. [Epub ahead of print].
-
(2014)
Angiogenesis
-
-
Boscolo, E.1
Coma, S.2
Luks, V.L.3
Greene, A.K.4
Klagsbrun, M.5
Warman, M.L.6
-
15
-
-
84922469410
-
Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations
-
PMID: 25292196
-
Osborn AJ, Dickie P, Neilson DE, Glaser K, Lynch KA, Gupta A, et al. Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations. Hum Mol Genet. 2015 24:926-933 doi: 10.1093/hmg/ddu505 PMID: 25292196
-
(2015)
Hum Mol Genet
, vol.24
, pp. 926-933
-
-
Osborn, A.J.1
Dickie, P.2
Neilson, D.E.3
Glaser, K.4
Lynch, K.A.5
Gupta, A.6
-
16
-
-
33750390130
-
The challenges of Proteus syndrome: Diagnosis and management
-
PMID: 16883308
-
Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet. 2006; 14:1151-1157. PMID: 16883308
-
(2006)
Eur J Hum Genet
, vol.14
, pp. 1151-1157
-
-
Biesecker, L.1
-
17
-
-
80053132881
-
Assessment and management of the orthopedic and other complications of Proteus syndrome
-
PMID: 23024722
-
Tosi LL, Sapp JC, Allen ES, O'Keefe RJ, Biesecker LG. Assessment and management of the orthopedic and other complications of Proteus syndrome. J Child Orthop. 2011; 5:319-327. PMID: 23024722
-
(2011)
J Child Orthop
, vol.5
, pp. 319-327
-
-
Tosi, L.L.1
Sapp, J.C.2
Allen, E.S.3
O'Keefe, R.J.4
Biesecker, L.G.5
-
18
-
-
84863337700
-
PI3K: A potential therapeutic target for cancer
-
PMID: 21938729
-
Chen Y, Wang BC, Xiao Y. PI3K: a potential therapeutic target for cancer. J Cell Physiol. 2012; 227:2818-2821. doi: 10.1002/jcp.23038 PMID: 21938729
-
(2012)
J Cell Physiol
, vol.227
, pp. 2818-2821
-
-
Chen, Y.1
Wang, B.C.2
Xiao, Y.3
|